2nd Influenza Research and Development
|
Register by June 8th, 2013 for a
10% Discount. Or Register 3
for the price of 2 with the coupon code RCDVB! |
|
Dear Colleague,
GTC is proud to announce its second annual Influenza Research and Development
Conference to be held in Boston, MA on July 8th-10th, 2013.
This conference will once again bring together experts from industry, government
and academia to discuss the issues facing the influenza field. Topics will range
from basic science of the influenza virus itself to pandemic preparedness to
vaccination and clinical development. Attend this conference to learn, discuss
and network with fellow scientists and researchers involved in various sectors
of the influenza filed in an intimate setting.
The 2nd Influenza Research and Development Conference is part of our
Infectious Diseases World Summit 2013 and will be held concurrently
with two other tracks which are:
11th Vaccines Research and Development: All Things Considered Conference
10th Anti-infectives Partnering and Deal-Making Conference
Sessions for the Influenza Conference Are:
Virology and Pathogenesis
Role of T-Cells and B-Cells
Immunity to Influenza
Influenza Pandemic Preparedness
Antivirals and Therapeutics
Antibodies and Vaccination
Members of the Advisory Board:
Susan Baldwin, Senior Scientist / Principle Investigator, IDRI
Dennis Christianson, Head of Section, Vaccine R&D, Infectious Disease
Immunology, Statens Serum Institute
Maryna Eichelberger, Senior Investigator, FDA
Adolfo Garcia-Sastre, Professor, Department of Microbiology, Mount Sinai School
of Medicine
Sarah Gilbert, Professor of Vaccinology, University of Oxford
Robert Huebner, Deputy Director, Influenza and Emerging Diseases Division, BARDA
Veronika von Messling, Associate Professor, INRS-Institut Armand-Frappier
Emanuel Montomoli, Professor of Public Health, University of Siena
Steve Rockman, Associate Director, Influenza Research & Development, Influenza Innovation, CSL Ltd
Ernst Soethout, Doctor of Veterinary Medicine, National Institute of Public
Health and Environment
Stephen Turner, Professor, Microbiology and Immunology, The University of
Melbourne
Ian Wilson, Hansen Professor of Structural Biology, The Scripps Research
Institute
Robert Webster, Rose Marie Thomas Chair, Infectious Diseases, St. Jude
Children’s Hospital
We look forward to seeing you at the conference!
Sincerely,
2013 Influenza Research & Development Organizing Committee
|
 |
Attend ALL GTC Conferences for One Year
for only $3995 ($1990 for acad/govt)
Click
here to sign up! |
What Past Delegates Said About the Event:
“The Influenza Research
and Development conference was a unique opportunity to hear about influenza and
the issues associated with Dual Use Research in light of the molecular changes
in H5N1 that would permit respiratory droplet transmission in ferrets as well as
strategies for future control including universal influenza vaccines.”
- Robert Webster, Rose Marie Thomas Chair, Division of Virology, Department of
Infectious Diseases, St. Jude Children's Research Hospital
"I really appreciate this meeting; the audience was perfect for the subjects
discussed and for networking in the influenza field. Different relevant topics
were presented, from immunogenicity to FDA and BARDA updates, which made this
meeting optimal."
- Sonia Trépanier, Ph. D., Director, Preclinical and Clinical Studies, Medicago
"The Influenza Research & Development Conference was an optima opportunity to
share recent developments in influenza field, both for research and vaccine
development as well."
- Emanuele Montomoli, Prof. on Public Health University of Siena ITALY
"It was a great meeting. The topics were focused yet covered all the subjects
currently of high interests. The size favored very good
interactions/networking. Importantly to me, the time allotted to each session
and subject was just enough and everything was on time and well coordinated.
Consequently, it was easy to go from room to room and cover different
presentations/subjects and access to the site from the airport was only 10 min."
- Gary Kobinger, Head, Vector Design and Immunotherapy, Special Pathogens Program, National
Microbiology Laboratory, Public Health Agency of Canada
"GTC’s Influenza Research & Development Conference in San Francisco, CA brought
together outstanding researchers in virology, immunology and vaccine design. The
meeting was highly interactive and offered great opportunities for both formal
and informal exchange of ideas. Overall, the topics of presentation, the
speakers and the attendees made this a highly stimulating venue for
consideration of the challenges that remain in for generating protective
immunity to influenza virus"
- Andrea J. Sant, Professor of Microbiology and Immunology University of
Rochester Medical School David H. Smith Center for Vaccine Biology and
Immunology
|
| |
